UnitedHealth Group Inc. Stock Performance

UnitedHealth Group Inc.’s stock price has declined from approximately $600 in April to around $275 in May, before recovering slightly to $325.

Q1 Results and Market Impact

The company’s release of disappointing Q1 results was the primary driver of the stock’s downturn. Key highlights from the Q1 results include:

• Revenue: $58.1 billion (compared to $57.1 billion in Q1 2022)
• Net earnings: $3.55 billion (compared to $3.04 billion in Q1 2022)
• Operating margin: 5.1% (compared to 4.8% in Q1 2022)

Q2 Challenges

Several factors have contributed to the stock’s decline in Q2, including:

• Continued market volatility
• Concerns over the Trump administration’s new tariffs
• Overall market uncertainty

Market Trends

The Dow Jones Industrial Average has also been affected by concerns over the Trump administration’s new tariffs, leading to a decline in the index. Key statistics include:

• Dow Jones Industrial Average: 24,700 (as of May 2023)
• Year-over-year change: -5.1%
• 52-week high: 29,568
• 52-week low: 23,850